O

Ovensa Inc.

3 employees

Ovensa provides nanomedicine delivery platform with mucosal and brain-barrier crossing properties to generate advanced nanotherapeutics,

Basic info

Industry

biotechnology research

Sectors

Peptide Therapeutics
Biotechnology
Immuno-Oncology Therapeutics
Extracellular & Intracellular Targeting
Precision & Combination Medicines
DNA & RNA Based Therapeutics
Nano Conjugates
Non Lipidic & Non Viral
Nanoparticles
Tumor Microenvironment Modulation
Therapeutics
Targeted Conjugation & Multi-Combination Product Designs
Brain Targeting
Medical
CNS Therapeutics

Date founded

2012

Funding rounds raised

Total raised

$1.4M

from 5 investors over 5 rounds

O

Ovensa Inc. raised $1.4M on September 12, 2017

Investors: Anges Québec, Aligo Innovation, société en commandite and AQC Capital

O

Ovensa Inc. raised $530K on June 8, 2016

Investors: Anges Québec and Aligo Innovation, société en commandite

FAQ